The Impact of Universal Glove and Gown Use on Clostridioides Difficile Acquisition: A Cluster-Randomized Trial
- PMID: 35776131
- DOI: 10.1093/cid/ciac519
The Impact of Universal Glove and Gown Use on Clostridioides Difficile Acquisition: A Cluster-Randomized Trial
Abstract
Background: Clostridioides difficile is the most common cause of healthcare-associated infections in the United States. It is unknown whether universal gown and glove use in intensive care units (ICUs) decreases acquisition of C. difficile.
Methods: This was a secondary analysis of a cluster-randomized trial in 20 medical and surgical ICUs in 20 US hospitals from 4 January 2012 to 4 October 2012. After a baseline period, ICUs were randomized to standard practice for glove and gown use versus the intervention of all healthcare workers being required to wear gloves and gowns for all patient contact and when entering any patient room (contact precautions). The primary outcome was acquisition of toxigenic C. difficile determined by surveillance cultures collected on admission and discharge from the ICU.
Results: A total of 21 845 patients had both admission and discharge perianal swabs cultured for toxigenic C. difficile. On admission, 9.43% (2060/21 845) of patients were colonized with toxigenic C. difficile. No significant difference was observed in the rate of toxigenic C. difficile acquisition with universal gown and glove use. Differences in acquisition rates in the study period compared with the baseline period in control ICUs were 1.49 per 100 patient-days versus 1.68 per 100 patient-days in universal gown and glove ICUs (rate difference, -0.28; generalized linear mixed model, P = .091).
Conclusions: Glove and gown use for all patient contact in medical and surgical ICUs did not result in a reduction in the acquisition of C. difficile compared with usual care.
Clinical trials registration: NCT01318213.
Keywords: Clostridioides difficile; antibiotic-resistance; barrier precautions; contact precautions.
Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022.
Conflict of interest statement
Potential conflicts of interest. E. R. D. reports grants or contracts from Synthetic Biologics, Ferring, and Pfizer, outside of the submitted work, and consulting fees from Seres, Merck, Pfizer, Abbott, and Ferring. S. L. reports grants/contracts to their institution under the CDC Prevention Epicenters and Broad Agency Agreement mechanisms in the broad field of infection prevention and healthcare epidemiology from the Centers for Disease Control and Prevention and a contract for Maryland hospital collaboratives on C. difficile and COVID-19 prevention from the Maryland Department of Health, all outside of the submitted work. T. H. reports grants or contracts paid to their institution from Synthetic Biologics, Inc, and CDC Epicenters, both outside of the submitted work. D. J. M. reports grants or contracts unrelated to this work from the National Institutes of Health, CDC, and Veterans Affairs Health Services Research and Development; reimbursement for travel from IDWeek and the Society for Healthcare Epidemiology of America (SHEA); and unpaid positions as Chair of the IDWeek SHEA Committee and as lead of the SHEA Diagnostic Stewardship Taskforce. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Similar articles
-
Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial.JAMA. 2013 Oct 16;310(15):1571-80. doi: 10.1001/jama.2013.277815. JAMA. 2013. PMID: 24097234 Free PMC article. Clinical Trial.
-
The Effect of Universal Glove and Gown Use on Adverse Events in Intensive Care Unit Patients.Clin Infect Dis. 2015 Aug 15;61(4):545-53. doi: 10.1093/cid/civ315. Epub 2015 Apr 21. Clin Infect Dis. 2015. PMID: 25900169 Clinical Trial.
-
Acquisition of Antibiotic-Resistant Gram-negative Bacteria in the Benefits of Universal Glove and Gown (BUGG) Cluster Randomized Trial.Clin Infect Dis. 2021 Feb 1;72(3):431-437. doi: 10.1093/cid/ciaa071. Clin Infect Dis. 2021. PMID: 31970393 Free PMC article. Clinical Trial.
-
Prevention of Infection due to Clostridium (Clostridioides) difficile.Infect Dis Clin North Am. 2021 Dec;35(4):995-1011. doi: 10.1016/j.idc.2021.07.009. Infect Dis Clin North Am. 2021. PMID: 34752229 Review.
-
A review of epidemiological models of Clostridioides difficile transmission and control (2009-2021).Anaerobe. 2022 Apr;74:102541. doi: 10.1016/j.anaerobe.2022.102541. Epub 2022 Feb 22. Anaerobe. 2022. PMID: 35217149 Review.
Cited by
-
Multidrug-Resistant Organisms: The Silent Plight of Burn Patients.J Burn Care Res. 2024 Aug 6;45(4):877-886. doi: 10.1093/jbcr/irae075. J Burn Care Res. 2024. PMID: 38695094 Free PMC article. Review.
-
Genomic surveillance of Clostridioides difficile transmission and virulence in a healthcare setting.mBio. 2024 Mar 13;15(3):e0330023. doi: 10.1128/mbio.03300-23. Epub 2024 Feb 8. mBio. 2024. PMID: 38329369 Free PMC article.
-
Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update.Infect Control Hosp Epidemiol. 2023 Apr;44(4):527-549. doi: 10.1017/ice.2023.18. Infect Control Hosp Epidemiol. 2023. PMID: 37042243 Free PMC article. No abstract available.
-
Contact precautions for the control of endemic pathogens: Finding the middle path.Antimicrob Steward Healthc Epidemiol. 2023 Mar 24;3(1):e57. doi: 10.1017/ash.2023.145. eCollection 2023. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 37008747 Free PMC article. No abstract available.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
